The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

Study summary

The Multi-OutcoMe EvaluatioN of radiation Therapy Using the Unity MR-Linac Study (MOMENTUM) is a multi-institutional, international registry facilitating evidenced based implementation of the Unity MR-Linac technology and further technical development of the MR-Linac system with the ultimate purpose to improve patients' survival, local, and regional tumor control and quality of life.

Ask AI to explain this study

Start here

Key things to know

Main goalNot specified

This describes the study’s primary purpose.

What is being studiedRadiation therapy

The study team can explain what participation involves.

Who it may be forOncology · Breast Cancer

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Mar 5, 2026 · Source: ClinicalTrials.gov

Is enrollment open?Recruiting

The study is currently accepting participants.

What kind of study?Not applicable

Observational

Where is it offered?18 U.S. locations

Locations may change over time.

Who runs it?UMC Utrecht

Study sponsor

Study overview

What this study is about

Purpose: Not specified
Study type: Observational
Phase: Not applicable
Sponsor: UMC Utrecht
Interventions being studied: Radiation: Radiation therapy

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach

Radiation therapy→

Study topics

Survivorship and quality of life→

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

Patient is to undergo or has completed imaging or treatment procedures on an MR-Linac;
Patient provides written, informed consent;
Patient is 18 years old or older.

Reasons someone may not be able to joinExclusion criteria

MRI

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

Allegheny Health NetworkPittsburgh, Pennsylvania
Md Anderson Cancer CenterHouston, Texas
Medical College of WisconsinMilwaukee, Wisconsin
Austin Health - Olivia Newton-John Cancer Wellness and Research CentreMelbourne
Insitut Jules BordetBrussels
Sunnybrook Health Sciences Centre/Odette Cancer CentreToronto, Ontario
University Health Network - Princess Margaret Cancer CenterToronto
Odense UniversitetshospitalOdense, Funen
Universitätsklinikum TübingenTübingen
Università degli Studi di BresciaBrescia
IRCCS Ospedale Sacro Cuore Don CalabriaNegrar
Netherlands Cancer Institute, Antoni van Leeuwenhoek HospitalAmsterdam

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Mar 5, 2026. Always confirm current availability with the study team.

View original record ↗